Cervical cancer screening efficacy using SurePath , ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society
Cytopathology · 2024-11 · 35 (6) · 770-775
DOI: 10.1111/cyt.13431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytopathology, online erschienen am 08.08.2024. Verfasst von Takahiro Koyanagi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Uterine Cervical Dysplasia, Cytodiagnosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Over the past decade, liquid‐based cytology has replaced conventional cytology for cervical cancer screening in many countries, including Japan. We aimed to evaluate the efficacy of liquid‐based cytology using a large database and compare two major liquid‐based cytology platforms, SurePath and ThinPrep, to conventional cytology.
Methods
Cervical cancer screening data were collected from the Japan Cancer Society between 2015 and 2019. The efficacy of liquid‐based and conventional cytology in detecting cervical intraepithelial neoplasia (CIN) was evaluated. Detection rates and positive predictive values were compared using a Poisson regression model.
Results
We collected data of 3,918,149 participants, including 2,248,202 conventional cytology, 874,807 SurePath and 795,140 ThinPrep smears. The detection rate of CIN2 or more was 1.14 times higher using SurePath than that using conventional cytology (95% confidence interval [CI], 1.09–1.20; p < 0.001). Contrastingly, the detection rate of CIN2 or more was 0.91 times lower using ThinPrep (95% CI, 0.86–0.96; p < 0.001). The detection rates of CIN3 or more did not differ significantly between SurePath and conventional cytology (detection rate ratio, 1.04; 95% CI, 0.97–1.12; p = 0.224). The positive predictive value ratios of CIN2 or more were 0.80 using SurePath (95% CI, 0.76–0.84; p < 0.001) and 0.83 using ThinPrep (95% CI, 0.79–0.87; p < 0.001) compared with conventional cytology.
Conclusions
Liquid‐based cytology, particularly SurePath, was useful for detecting CIN2 or higher in population‐based cervical cancer screening. Further widespread use of liquid‐based cytology methods would lead to efficient detection of cervical precancerous lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, School of Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Department of Biostatistics, Yokohama City University, Yokohama, Kanagawa, Japan.
- Department of Obstetrics and Gynecology, Shin-yurigaoka General Hospital, Kawasaki, Kanagawa, Japan.
- The Japan Cancer Society, Chuo-ku, Tokyo, Japan.
ORCID-Profile: Takahiro Koyanagi
Zitieren
APA
Koyanagi, T., Fujiwara, H., Yamamoto, K., Suzuki, M., & Kakizoe, T. (2024). Cervical cancer screening efficacy using SurePath , ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society. Cytopathology, 35(6), 770-775. https://doi.org/10.1111/cyt.13431
Vancouver
Koyanagi T, Fujiwara H, Yamamoto K, Suzuki M, Kakizoe T. Cervical cancer screening efficacy using SurePath , ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society. Cytopathology. 2024;35(6):770-775. doi:10.1111/cyt.13431
BibTeX
@article{Koyanagi2024,
author = {Koyanagi, Takahiro and Fujiwara, Hiroyuki and Yamamoto, Kouji and Suzuki, Mitsuaki and Kakizoe, Tadao},
title = {Cervical cancer screening efficacy using SurePath , ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society},
journal = {Cytopathology},
year = {2024},
volume = {35},
number = {6},
pages = {770--775},
doi = {10.1111/cyt.13431}
}
EUVIMED